000 | 01173 a2200313 4500 | ||
---|---|---|---|
005 | 20250518025132.0 | ||
264 | 0 | _c20200217 | |
008 | 202002s 0 0 eng d | ||
022 | _a1534-3111 | ||
024 | 7 |
_a10.1007/s11906-019-0924-0 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aManolis, Antonis A | |
245 | 0 | 0 |
_aEplerenone Versus Spironolactone in Resistant Hypertension: an Efficacy and/or Cost or Just a Men's Issue? _h[electronic resource] |
260 |
_bCurrent hypertension reports _c03 2019 |
||
300 |
_a22 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAldosterone |
650 | 0 | 4 |
_aAntihypertensive Agents _xtherapeutic use |
650 | 0 | 4 |
_aEplerenone _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertension _xdrug therapy |
650 | 0 | 4 |
_aMineralocorticoid Receptor Antagonists _xtherapeutic use |
650 | 0 | 4 |
_aSpironolactone _xtherapeutic use |
700 | 1 | _aManolis, Theodora A | |
700 | 1 | _aMelita, Helen | |
700 | 1 | _aManolis, Antonis S | |
773 | 0 |
_tCurrent hypertension reports _gvol. 21 _gno. 3 _gp. 22 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11906-019-0924-0 _zAvailable from publisher's website |
999 |
_c29434079 _d29434079 |